936 Results

People

  1. Tap
    Tap
  2. D'Angelo
    D'Angelo
  3. Gounder
    Gounder
  4. Chi
    Chi
  5. Dickson
    Dickson
  6. Antonescu
    Antonescu
  7. Keohan
    Keohan
  8. Singer
    Singer
  9. Kelly
    Kelly
  10. Qin
    Qin

Groups

  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)
  7. Department of Pathology and Laboratory Medicine (237)
  8. Human Oncology and Pathogenesis Program (232)
  9. Surgery (199)
  10. Sarcoma Surgeons (142)
  1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient-reported outcome instruments meaningful and relevant for tenosynovial giant cell tumor (TGCT): A qualitative study
    Meeting Abstract

    Gelhorn, H.; Tong, S.; Maclaine, G.; Healey, J. H.; Bukata, S. V.; Keedy, V. L.; Anthony, S. P.; Wagner, A. J.; Von Hoff, D. D.; Singh, A. S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Physician toxicity attribution in phase I trials: Evaluating the effect of dose on the frequency of 11,909 toxicities
    Meeting Abstract

    Eaton, A.; Iasonos, A.; Gounder, M. M.; Pamer, E.; Drilon, A. E.; Vulih, D.; Smith, G. L.; Ivy, P.; Spriggs, D. R.; Hyman, D. M.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Dermatologic toxicities of 3,517 solid tumor patients on phase I clinical trials of the National Institutes of Health Cancer Therapy Evaluation Program (CTEP)
    Meeting Abstract

    Drilon, A. E.; Eaton, A.; Schindler, K.; Gounder, M. M.; Smith, G. L.; Vulih, D.; Harris, P. J.; Spriggs, D. R.; Ivy, P.; Iasonos, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Metastatic non-uterine leiomyosarcoma: Prognostic factors, overall survival and chemotherapy outcomes
    Meeting Abstract

    D'Angelo, S. P.; Shoushtari, A. N.; Landa, J.; Kuk, D.; Sanchez, A. J.; Lala, B.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Tap, W. D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase Ib/II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Chi, P.; Qin, L. X.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Shoushtari, A. N.; Condy, M. M.; Konen, T.; Fruauff, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • SARC 028: A phase II study of the anti-PD1 antibody pembrolizumab (P) in patients (Pts) with advanced sarcomas
    Meeting Abstract

    Burgess, M. A.; Crowley, J.; Reinke, D. K.; Riedel, R. F.; George, S.; Movva, S.; Van Tine, B. A.; Davis, L. E.; Schuetze, S.; Hu, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I study of MEDI6383, an OX40 agonist, in adult patients with select advanced solid tumors
    Meeting Abstract

    Bauer, T. M.; Chae, Y. K.; Patel, S.; D'Angelo, S. P.; Blumenschein, G. R.; Norton, J.; Pound, C.; Lanasa, M. C.; Curti, B. D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials
    Journal Article

    Hyman, D. M.; Eaton, A. A.; Gounder, M. M.; Pamer, E. G.; Pettiford, J.; Carvajal, R. D.; Percy Ivy, S.; Iasonos, A.; Spriggs, D. R.
    Oncotarget (2015)

    Fulltext@MSK | Save
  • Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor
    Journal Article

    Tap, W. D.; Wainberg, Z. A.; Anthony, S. P.; Ibrahim, P. N.; Zhang, C.; Healey, J. H.; Chmielowski, B.; Staddon, A. P.; Lee Cohn, A.; Shapiro, G. I.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Phase I study of XL281 (BMS-908662), a potent oral RAF kinase inhibitor, in patients with advanced solid tumors
    Journal Article

    Dickson, M. A.; Gordon, M. S.; Edelman, G.; Bendell, J. C.; Kudchadkar, R. R.; LoRusso, P. M.; Johnston, S. H.; Clary, D. O.; Schwartz, G. K.
    Investigational New Drugs (2015)

    Fulltext@MSK | Save